Safety and Efficacy Study of Interferon to Treat Patients Hospitalized for Influenza

NCT01227798 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Influenza

Interventions

DRUG: Interferon alfacon-1
DRUG: Placebo

Sponsor

University Health Network, Toronto